We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




PEF Cardiac Ablation System Reduces Collateral Damage

By HospiMedica International staff writers
Posted on 21 Oct 2020
An innovative cardiac ablation system utilizes high voltage, high frequency, pulsed electric field (PEF) energy to ablate tissue.

The Galaxy Medical (San Carlos, CA, USA) Centauri System is an open energy platform that uses PEF technology to improve the safety and efficacy of cardiac ablation by reducing unintentional conductive heating or cooling of extracardiac structures, such as the esophagus, phrenic nerve, and airway. More...
Efficacy is enhanced by creation of full-thickness, transmural lesions, as therapeutic doses of PEF energy are limited to the myocardium. Hardware and waveform control algorithms enable electrophysiologists to continue with their established point-by-point clinical workflow, as used in the majority of cardiac ablation procedures.

Key features of the Centauri System include a proprietary user interface; plug and play interfacing with all cardiac mapping and navigation systems; no-compromise compatibility with market-released focal and contact-force sensing catheters; choice of dose settings when treating variable tissue thickness; a proprietary technology that completely eliminates microbubbles (which may cause cerebral or coronary air emboli during PEF delivery); and automated voltage control to prevent both over- and under-dosing. A multicenter trial, the ECLIPSE-AF study, is underway to assess the safety and efficacy of the Centauri System

“Our research has consistently demonstrated that PEF with focal catheters yields predictable and transmural lesions, as opposed to inconsistent ablation depth and intermittent electrical stunning associated with multipolar catheters with variable contact,” said Jonathan Waldstreicher, MD, CEO of Galaxy Medical. “We look forward to completing enrollment of the ECLIPSE-AF study and sharing the clinical experience in the near future.”

“The Galaxy Medical Centauri System operated seamlessly within my atrial fibrillation ablation clinical workflow,” said Ante Anić, MD, electrophysiology lab director at University Hospital Split (Croatia), and primary investigator of the ECLIPSE-AF study. “PEF energy is the future of electrophysiology, and Centauri allowed me to deliver it with a standard focal ablation technique to patients under conscious sedation, and without compromising on the ablation catheter, contact force feedback, or cardiac mapping system.”

Cardiac catheter ablation procedures are used to treat a variety of cardiac arrhythmias, especially supraventricular tachyarrhythmias such as atrial fibrillation (AF), atrial flutter, and atrial tachycardia. The procedures involve advancing a catheter into the heart and selectively ablating certain areas of tissue in order to prevent the spread of the electrical signals that give rise to the arrhythmia.

Related Links:
Galaxy Medical


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
X-Ray Meter
Cobia SENSE
Digital X-Ray Detector Panel
Acuity G4
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.